Biological Sciences and Healthcare, part 4

Substance > Drug or medicament (substance) > Antineoplastic agent (substance) > Lenvatinib mesylate (substance)

... > Substance > Substance categorised structurally > Chemical > Chemical categorised structurally > Organic chemical > Organic nitrogen compound > Amines and their derivatives > Quinoline > Lenvatinib mesylate (substance)

... > Substance > Substance categorised structurally > Chemical > Chemical categorised structurally > Nitrogen and nitrogen compound (substance) > Nitrogen compound > Organic nitrogen compound > Amines and their derivatives > Quinoline > Lenvatinib mesylate (substance)

Substance > Drug or medicament (substance) > Quinoline > Lenvatinib mesylate (substance)

... > Substance > Substance categorised structurally > Chemical > Chemical categorised structurally > Organic chemical > Organic cyclic compound > Heterocyclic compound > Quinoline > Lenvatinib mesylate (substance)

Substance > Substance categorized by disposition > Substance with receptor antagonist mechanism of action (substance) > Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) > Lenvatinib mesylate (substance)

... > Substance > Substance categorised structurally > Chemical > Chemical categorised structurally > Organic chemical > Organic cyclic compound > Substance with cyclopropane structure (substance) > Lenvatinib mesylate (substance)

... > Substance > Substance categorized by disposition > Substance with effector mechanism of action (substance) > Enzyme inhibitor (substance) > Transferase inhibitor (substance) > Phosphotransferase inhibitor (substance) > Protein kinase inhibitor (substance) > Protein-tyrosine kinase inhibitor (substance) > Lenvatinib mesylate (substance)